Related Experiment Video
Updated: May 20, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Nanoproteomics enabling personalized nanomedicine.
Claudio Nicolini1, Nicola Bragazzi, Eugenia Pechkova
1Nanobiotechnology and Biophysics Laboratories, Department Experimental Medicine, University of Genoa, Italy. cnicolini@ibf.unige.it
A new label-free protein array method using nanotechnologies analyzes protein function and interactions. This advance offers promising applications for personalized medicine by overcoming limitations of fluorescent detection methods.
Area of Science:
- Biotechnology
- Nanotechnology
- Proteomics
Background:
- Mammalian cell-free expression systems enable in situ protein production.
- Fluorescent-labeled detection methods for protein analysis face background noise limitations.
- Personalized medicine requires precise tools for analyzing protein function and interactions.
Purpose of the Study:
- To develop and validate a novel label-free protein array for analyzing protein function and interactions.
- To overcome the limitations of traditional fluorescence-based detection in protein analysis.
- To explore the potential of this technology for applications in personalized medicine.
Main Methods:
- Utilized a combination of three complementary nanotechnological approaches: Quartz Micro Circuit nanogravimetry, mass spectrometry, and anodic porous alumina.
- Developed a label-free detection strategy as an alternative to fluorescent-labeled methods.
- Employed a mammalian cell-free expression system for protein production.
Main Results:
- The label-free nanotechnological approach successfully analyzed protein function and protein-protein interactions.
- This method overcomes background noise issues inherent in correlated fluorescence detection.
- Demonstrated the potential for optimizing protein quantification using a defined bacterial cell-free expression system.
Conclusions:
- The developed label-free protein array represents a significant advancement in protein analysis technology.
- This method holds considerable promise for enhancing diagnostic and therapeutic strategies in personalized medicine.
- Further optimization with bacterial cell-free systems could enable quantification of human regulatory protein networks.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

